SAN

73.08

+0.05%↑

SRT3

217.45

+1.12%↑

ORNBV.FI

-3.72%↓

PHMA

95.6

-1.49%↓

DRW3

-2.06%↓

SAN

73.08

+0.05%↑

SRT3

217.45

+1.12%↑

ORNBV.FI

-3.72%↓

PHMA

95.6

-1.49%↓

DRW3

-2.06%↓

SAN

73.08

+0.05%↑

SRT3

217.45

+1.12%↑

ORNBV.FI

-3.72%↓

PHMA

95.6

-1.49%↓

DRW3

-2.06%↓

SAN

73.08

+0.05%↑

SRT3

217.45

+1.12%↑

ORNBV.FI

-3.72%↓

PHMA

95.6

-1.49%↓

DRW3

-2.06%↓

SAN

73.08

+0.05%↑

SRT3

217.45

+1.12%↑

ORNBV.FI

-3.72%↓

PHMA

95.6

-1.49%↓

DRW3

-2.06%↓

Home・Akcijų sąrašas・Vetoquinol SA

Vetoquinol SA

Atidarymo kaina

SektoriusSveikatos priežiūra

77.1 1.31

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

76.5

Max

77.1

Pagrindiniai rodikliai
By Trading Economics
Pajamos	25M
Pardavimai	10M 268M
P/E Sektoriaus vid.	14.588 49.8
Dividendų pajamingumas	1.21
Pelno marža	9.734
Darbuotojai	2,497
EBITDA	252M 301M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+48.05% upside

Dividendai
By Dow Jones
Dividendų pajamingumas Sektoriaus vid.	1.21% 2.25%

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-57M 878M
Ankstesnė atidarymo kaina	75.79
Ankstesnė uždarymo kaina	77.1

Naujienos nuotaikos

By Acuity

50%

153 / 347 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bearish Evidence

72.6 / 75.1 Palaikymas ir pasipriešinimas

Vetoquinol SA Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-05-10 23:47; UTC

Rinkos pokalbiai

Gold Falls on Renewed Inflation Concerns -- Market Talk

2026-05-10 23:44; UTC

Rinkos pokalbiai

Nikkei May Rise on Signs of U.S. Economic Strength -- Market Talk

2026-05-10 23:38; UTC

Rinkos pokalbiai

Oil Rises Amid Signs of Ongoing Middle East Tensions -- Market Talk

2026-05-10 23:14; UTC

Rinkos pokalbiai

Australia's Political Map Continues to Be Redrawn -- Market Talk

2026-05-10 22:22; UTC

Įsigijimai, susijungimai, perėmimai

Elevra Lithium: Expects Deal to Close in 1Q FY27

2026-05-10 22:21; UTC

Įsigijimai, susijungimai, perėmimai

Elevra Lithium: Expects to Received About $71 Million Before Fees, Taxes in Cash

2026-05-10 22:21; UTC

Įsigijimai, susijungimai, perėmimai

Elevra Lithium Agrees to Sell Ewoyaa Lithium Project Stake to Zhejiang Huayou Cobalt

2026-05-10 10:21; UTC

Uždarbis

Saudi Aramco Profit Jumps Despite War Disrupting Shipping Routes -- WSJ

2026-05-09 06:05; UTC

Uždarbis

Our Innodata Stock Pick Smashed Earnings Expectations. Stay Long. -- Barrons.com

2026-05-08 23:55; UTC

Uždarbis

Review & Preview: Still Going Strong -- Barrons.com

2026-05-08 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-05-08 20:49; UTC

Uždarbis

Why the Gap Between Chip and Software Stocks Keeps Getting Wider -- Barrons.com

2026-05-08 20:25; UTC

Uždarbis

These Stocks Are Today's Movers: Rocket Lab, Moderna, HubSpot, Nvidia, CoreWeave, Trade Desk, Cloudflare, Fluor, Akamai, IREN, and More -- Barrons.com

2026-05-08 19:43; UTC

Uždarbis

Cencosud 1Q Rev $4.565B >CENCOSUD.SN

2026-05-08 19:43; UTC

Uždarbis

Cencosud 1Q Net $115M

2026-05-08 19:20; UTC

Rinkos pokalbiai

Oil Futures End Session Higher, But Down on the Week -- Market Talk

2026-05-08 19:18; UTC

Uždarbis

Monster and Celsius Earnings Show Energy-Drink Fatigue Is Far From Over -- Barrons.com

2026-05-08 19:16; UTC

Uždarbis

This Mini Berkshire Hathaway Is a Buy. An Activist Investor Is Pushing to Break It Up. -- Barrons.com

2026-05-08 19:08; UTC

Uždarbis

This Mini Berkshire Hathaway Is a Buy. An Activist Investor Is Pushing to Break It Up. -- Barrons.com

2026-05-08 19:05; UTC

Uždarbis

Investors Feared Energy-Drink Fatigue. Monster and Celsius Earnings Offered Reassurance. -- Barrons.com

2026-05-08 19:02; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Little Changed on Week -- Market Talk

2026-05-08 18:51; UTC

Uždarbis

Memory Stocks Continue to Surge. What's Driving Micron and Sandisk Higher. -- Barrons.com

2026-05-08 18:49; UTC

Uždarbis

These Stocks Are Today's Movers: Rocket Lab, Moderna, HubSpot, Nvidia, CoreWeave, Trade Desk, Cloudflare, Fluor, Akamai, IREN, and More -- Barrons.com

2026-05-08 18:41; UTC

Uždarbis

McDonald's Stock Rises on Earnings Beat. The Value Push Needs to Maintain Momentum. -- Barrons.com

2026-05-08 17:38; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Rises By 2 to 410 -- Market Talk

2026-05-08 17:14; UTC

Uždarbis

How High Gas Prices Need to Rise to Boost Electric Vehicle Sales -- Barrons.com

2026-05-08 17:04; UTC

Rinkos pokalbiai

Zcash Caps Off Parabolic Week -- Market Talk

2026-05-08 16:20; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-05-08 16:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-05-08 16:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Vetoquinol SA Prognozė

Kainos tikslas

By TipRanks

48.05% į viršų

12 mėnesių prognozė

Vidutinis 110 EUR 48.05%

Aukščiausias 110 EUR

Žemiausias 110 EUR

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Vetoquinol SA kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

1 ratings

Pirkti

Laikyti

Parduoti

Remiantis 1 analitikų, pateikusių Vetoquinol SA akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

72.6 / 75.1Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

All events are bearish.

Rinkos nuotaikos

By Acuity

153 / 347 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.